Modeling timelines for translational science in cancer; the impact of technological maturation.

by Laura M McNamee, Fred D Ledley
Published 2017-01-01

As Technologies for Nucleotide Therapeutics Mature, Products Emerge

by Jennifer M. Beierlein, Laura M. McNamee, Fred D. Ledley
Published 2017-12-01

Timelines of translational science: From technology initiation to FDA approval.

by Laura M McNamee, Michael Jay Walsh, Fred D Ledley
Published 2017-01-01

Comparing long-term value creation after biotech and non-biotech IPOs, 1997-2016.

by Ekaterina Galkina Cleary, Laura M McNamee, Skyler de Boer, Jeremy Holden, Liam Fitzgerald, Fred D Ledley
Published 2021-01-01